Annual CFI
-$3.00 M
-$3.00 M-100.00%
December 31, 2023
Summary
- As of February 7, 2025, ATXI annual cash flow from investing activities is -$3.00 million, with the most recent change of -$3.00 million (-100.00%) on December 31, 2023.
- During the last 3 years, ATXI annual CFI has fallen by -$2.00 million (-200.00%).
- ATXI annual CFI is now -130.00% below its all-time high of $10.00 million, reached on December 31, 2018.
Performance
ATXI Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 7, 2025, ATXI quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, ATXI quarterly CFI has stayed the same.
- ATXI quarterly CFI is now -100.00% below its all-time high of $10.00 million, reached on March 31, 2018.
Performance
ATXI Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
+$1.00 M+100.00%
September 30, 2024
Summary
- As of February 7, 2025, ATXI TTM cash flow from investing activities is $0.00, with the most recent change of +$1.00 million (+100.00%) on September 30, 2024.
- Over the past year, ATXI TTM CFI has increased by +$3.00 million (+100.00%).
- ATXI TTM CFI is now -100.00% below its all-time high of $10.00 million, reached on September 30, 2018.
Performance
ATXI TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ATXI Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | 0.0% | +100.0% |
| 3 y3 years | -200.0% | - | - |
| 5 y5 years | -130.0% | 0.0% | +100.0% |
ATXI Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | at high | +100.0% | at high | +100.0% |
| 5 y | 5-year | <-9999.0% | at low | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -130.0% | +70.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Avenue Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Jun 2024 | - | $0.00(0.0%) | -$1.00 M(-66.7%) |
| Dec 2023 | -$3.00 M(<-9900.0%) | $0.00(-100.0%) | -$3.00 M(0.0%) |
| Sep 2023 | - | -$1.00 M(-50.0%) | -$3.00 M(+50.0%) |
| Jun 2023 | - | -$2.00 M(<-9900.0%) | -$2.00 M(<-9900.0%) |
| Dec 2022 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2022 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2020 | -$1.00 M(<-9900.0%) | $0.00(0.0%) | -$1.00 M(-125.0%) |
| Sep 2020 | - | $0.00(0.0%) | $4.00 M(0.0%) |
| Jun 2020 | - | $0.00(-100.0%) | $4.00 M(-500.0%) |
| Mar 2020 | - | -$1.00 M(-120.0%) | -$1.00 M(<-9900.0%) |
| Dec 2019 | $0.00 | $5.00 M(>+9900.0%) | $0.00(-100.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2019 | - | $0.00(-100.0%) | -$5.00 M(0.0%) |
| Jun 2019 | - | -$5.00 M(<-9900.0%) | -$5.00 M(<-9900.0%) |
| Mar 2019 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Dec 2018 | $10.00 M(-200.0%) | $0.00(0.0%) | $10.00 M(0.0%) |
| Sep 2018 | - | $0.00(0.0%) | $10.00 M(>+9900.0%) |
| Jun 2018 | - | $0.00(-100.0%) | $0.00(0.0%) |
| Mar 2018 | - | $10.00 M(>+9900.0%) | $0.00(-100.0%) |
| Dec 2017 | -$10.00 M(<-9900.0%) | $0.00(-100.0%) | -$10.00 M(0.0%) |
| Sep 2017 | - | -$10.00 M(<-9900.0%) | -$10.00 M(<-9900.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2016 | $0.00 | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2016 | - | $0.00 | $0.00 |
FAQ
- What is Avenue Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Avenue Therapeutics?
- What is Avenue Therapeutics annual CFI year-on-year change?
- What is Avenue Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Avenue Therapeutics?
- What is Avenue Therapeutics quarterly CFI year-on-year change?
- What is Avenue Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Avenue Therapeutics?
- What is Avenue Therapeutics TTM CFI year-on-year change?
What is Avenue Therapeutics annual cash flow from investing activities?
The current annual CFI of ATXI is -$3.00 M
What is the all time high annual CFI for Avenue Therapeutics?
Avenue Therapeutics all-time high annual cash flow from investing activities is $10.00 M
What is Avenue Therapeutics annual CFI year-on-year change?
Over the past year, ATXI annual cash flow from investing activities has changed by -$3.00 M (-100.00%)
What is Avenue Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ATXI is $0.00
What is the all time high quarterly CFI for Avenue Therapeutics?
Avenue Therapeutics all-time high quarterly cash flow from investing activities is $10.00 M
What is Avenue Therapeutics quarterly CFI year-on-year change?
Over the past year, ATXI quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Avenue Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ATXI is $0.00
What is the all time high TTM CFI for Avenue Therapeutics?
Avenue Therapeutics all-time high TTM cash flow from investing activities is $10.00 M
What is Avenue Therapeutics TTM CFI year-on-year change?
Over the past year, ATXI TTM cash flow from investing activities has changed by +$3.00 M (+100.00%)